NeuroSense Therapeutics Ltd. Restricted Cash and Investments, Noncurrent
NeuroSense Therapeutics Ltd. (NRSN) had Restricted Cash and Investments, Noncurrent of $22.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndInvestmentsNoncurrent · last filed 2026-03-31
- 2025-12-31: Restricted Cash and Investments, Noncurrent $22.00K.
- 2025-06-30: Restricted Cash and Investments, Noncurrent $23.00K.
- 2024-12-31: Restricted Cash and Investments, Noncurrent $23.00K.
- 2024-06-30: Restricted Cash and Investments, Noncurrent $22.00K.
| Period end | Restricted Cash and Investments, Noncurrent |
|---|---|
| 2025-12-31 | $22.00K 20-F · filed 2026-03-31 |
| 2025-06-30 | $23.00K 6-K · filed 2025-08-01 |
| 2024-12-31 | $23.00K 20-F · filed 2026-03-31 |
| 2024-06-30 | $22.00K 6-K · filed 2024-09-30 |
| 2023-12-31 | $22.00K 20-F · filed 2025-04-07 |
| 2022-12-31 | $23.00K 6-K · filed 2024-06-17 |